Literature DB >> 17511739

Usefulness of laparo- or retroperitoneoscopic biopsy for retroperitoneal lymph node swelling of unknown origin.

Isao Hara1, Kazushi Tanaka, Yuji Yamada, Hideaki Miyake, Atsushi Takenaka, Masato Fujisawa.   

Abstract

Laparo- or retroperitoneoscopic biopsy was performed for five male patients with retroperitoneal lymph node swelling of unknown origin. Previous core needle biopsies were useless or inapplicable in all patients. A laparoscopic approach was used for two patients, with a retroperitoneoscopic approach for the remaining three patients. Sufficient specimens for not only pathological diagnosis but also further examinations such as immunophenotyping or DNA analysis were safely obtained. Convalescence was satisfactory and all patients were treated appropriately according to the resulting diagnosis. This technique should be performed by urologists, who are more familiar with laparo- or retroperitoneoscopic approach targeting retroperitoneal organs.

Entities:  

Mesh:

Year:  2007        PMID: 17511739     DOI: 10.1111/j.1442-2042.2007.01738.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

1.  Diagnostic laparoscopic biopsy for intraabdominal tumors.

Authors:  Yasuo Sakamoto; Ryuichi Karashima; Satoshi Ida; Yu Imamura; Shiro Iwagami; Yoshifumi Baba; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2014-09-12       Impact factor: 2.549

2.  Advantage of urological experience with both transperitoneal and retroperitoneal laparoscopy in lymph node biopsy for malignant lymphoma diagnosis.

Authors:  Hiroaki Kawanishi; Katsuhiro Ito; Satoshi Kamido; Yuka Kohno; Toshihiro Uemura; Keiji Kato; Hirotsugu Uetsuki; Hitoshi Ohno; Kazuhiro Okumura
Journal:  Investig Clin Urol       Date:  2016-10-25

3.  Diagnostic challenge for giant left retroperitoneal accessory spleen: a case report.

Authors:  Youjian Li; Xuefeng Qiu; Weijian Li; Hongqian Guo; Xiaogong Li
Journal:  J Int Med Res       Date:  2019-09-24       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.